Cite
HARVARD Citation
Galsky, M. et al. (2013). Relationship between 6‐ and 9‐month progression‐free survival and overall survival in patients with metastatic urothelial cancer treated with first‐line cisplatin‐based chemotherapy. Cancer. 119 (16), pp. 3020-3026. [Online].